![Anne Lesage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 M $ al 31/07/2026
Anne Lesage is the founder of GrayMatters Consulting BV, founded in 2010.
Dr. Lesage is the founder of Kosa Pharma GmbH, founded in 2013.
Dr. Lesage is the founder of Pharvaris NV, founded in 2015, holding the title of Chief Early Development Officer since 2015.
Dr. Lesage is the founder of Pharvaris GmbH, founded in 2015, holding the title of Chief Early Development Officer since 2015.
Dr. Lesage completed a doctorate degree at Ghent University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PHARVARIS N.V. 0,22 % | 30/06/2026 | 152.719 ( 0,22 % ) | 5 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARVARIS N.V. | Fundador | 30/09/2015 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Fundador | 01/10/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
Kosa Pharma GmbH | Fundador | - |
GrayMatters Consulting BV | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
GrayMatters Consulting BV | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kosa Pharma GmbH |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
